Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan

被引:0
|
作者
Nguyen, Teresa [1 ]
Bareham, Julia [2 ]
Halpape, Katelyn [3 ]
机构
[1] Loblaw Pharm Saskatoon, Saskatoon, SK, Canada
[2] Univ Saskatchewan, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[3] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
COLLABORATIVE CARE; BUPRENORPHINE; EXPERIENCE; ABSTINENCE; ADDICTION; METHADONE;
D O I
10.46747/cfp.7004e52
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To explore barriers and facilitators for family physicians in Saskatchewan prescribing opioid agonist therapy (OAT). Design Self-administered postal survey. Setting Family medicine practices in Saskatchewan. Participants A total of 218 Saskatchewan family physicians who were not authorized to prescribe OAT as of June 2022. Main outcome measures Descriptive and inferential statistics of physicians' self-reported barriers to and facilitators of prescribing OAT for opioid use disorder (OUD). Results Most respondents (84.8%) had some comfort with diagnosing OUD. However, more than half (58.3%) did not feel confident or knowledgeable about prescribing OAT. Barriers to OAT prescribing included lack of time, incomplete training requirements, lack of interest, insufficient funding or support, feeling overwhelmed, and perceiving that OAT does not work and thus is not necessary. Physicians working in core neighbourhoods and those receiving fee-for-service compensation reported the least available time to prescribe OAT. Conversely, physicians working in interdisciplinary team settings had increased time for OAT prescribing compared with physicians in other settings. Having a close personal relationship with someone with OUD was correlated with increased comfort in diagnosing OUD as well as with knowledge about and confidence in prescribing OAT. Themes identified as facilitators to increasing OAT prescribing included the addition of resources and supports, increased training, more awareness about OUD and OAT, enhanced compensation, and altered prescribing regulations. Conclusion Despite the presence of several real and perceived barriers limiting OAT prescribing by Saskatchewan family physicians, there are family physicians interested in providing this therapy. Increased clinical resources and support, including increased interdisciplinary practice, are actionable steps that should be considered by policy decision makers to address this issue. Additionally, increased OUD and OAT education, which includes the perspectives of those with lived experience of OUD, would help address physician confidence, knowledge, and awareness in this area.
引用
收藏
页码:e52 / e60
页数:9
相关论文
共 50 条
  • [31] Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study
    L. Desveaux
    M. Saragosa
    N. Kithulegoda
    N. M. Ivers
    BMC Family Practice, 20
  • [32] Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study
    Desveaux, L.
    Saragosa, M.
    Kithulegoda, N.
    Ivers, N. M.
    BMC FAMILY PRACTICE, 2019, 20 (1)
  • [33] An overview of legal and policy barriers to opioid analgesics access and opioid agonist therapy in Morocco
    Tinasti, Khalid
    Outaleb, Lahcen
    DRUGS HABITS AND SOCIAL POLICY, 2023, 24 (04): : 252 - 258
  • [34] Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study
    Bates, Aaron E.
    Martin-Misener, Ruth
    CANADIAN JOURNAL OF NURSING RESEARCH, 2022, 54 (01) : 15 - 26
  • [35] A Longitudinal Qualitative Study of Barriers and Facilitators of Breastfeeding in Women on Opioid Maintenance Therapy
    Doerzbacher, Margaret
    Sperlich, Mickey
    Hequembourg, Amy
    Chang, Yu-Ping
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2024, 38 (03) : 306 - 314
  • [36] Barriers and Facilitators of Artificial Intelligence in Family Medicine: An Empirical Study With Physicians in Saudi Arabia
    Alanzi, Turki
    Alotaibi, Raghad
    Alajmi, Rahaf
    Bukhamsin, Zainab
    Fadaq, Khadija
    AlGhamdi, Nouf
    Khamsin, Norah Bu
    Alzahrani, Lujain
    Abdullah, Ruya
    Alsayer, Razan
    Al Muarfaj, Afrah M.
    Alanzi, Nouf
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [37] The epidemic of unrelieved chronic pain - The ethical, societal, and regulatory barriers facing opioid prescribing physicians
    Reddy, Bhavani S.
    JOURNAL OF LEGAL MEDICINE, 2006, 27 (04) : 427 - 442
  • [38] Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians
    Andrilla, C. Holly A.
    Moore, Tessa E.
    Patterson, Davis G.
    JOURNAL OF RURAL HEALTH, 2019, 35 (01): : 113 - 121
  • [39] Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission
    Bachireddy, Chethan
    Weisberg, Daniel F.
    Altice, Frederick L.
    ADDICTION, 2015, 110 (12) : 1869 - 1871
  • [40] Barriers and Facilitators to the Success of Black Academic Physicians
    Jerome, Barbara
    Fassiotto, Magali
    Maldonado, Yvonne
    Dunn, Tamara
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024,